TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/11 17:15 | 1/5/11 | GNTA | Genta Inc De/ | DE | Health | BioPrd | Biological Products, (No Diag | Itri Lorettta M | NJ | O | P R,D Ch | S.dm | -63 | 0.0183 | 0 | -3,456 | 0 | 1,126,761 | D | ||||||||||||||
12/18/09 16:56 | 12/15/09 | GETA | Genta Inc De/ | DE | Health | BioPrd | Biological Products, (No Diag | Itri Lorettta M | NJ | O | P,CMO | S.m | -253 | 0.0813 | 0 | -3,114 | -6 | 47,188 | D | ||||||||||||||
11/16/06 15:09 | 11/16/06 | GNTA | Genta Inc De/ | DE | Health | BioPrd | Biological Products, (No Diag | Itri Lorettta M | NJ | O | P,Pharm. | P | 20 | 0.7600 | 0 | 26 | 35 | 100 | D | ||||||||||||||
8/17/05 16:51 | 8/17/05 | GNTA | Genta Inc De/ | DE | Health | BioPrd | Biological Products, (No Diag | Itri Lorettta M | NJ | O | P Pharm. | P | 53 | 1.05 | 0 | 50 | 208 | 74 | D | ||||||||||||||
11/17/03 15:00 | 11/17/03 | GNTA | Genta Inc De/ | DE | Health | BioPrd | Biological Products, (No Diag | Itri Lorettta M | NJ | O | P Pharma | P | 97 | 9.68 | 0 | 10 | 59 | 27 | I | ||||||||||||||
9/12/03 15:34 | 9/12/03 | GNTA | Genta Inc De/ | DE | Health | BioPrd | Biological Products, (No Diag | Itri Lorettta M | NJ | O | P Pharma | P | 147 | 14.70 | 0 | 10 | 143 | 17 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |